骨关节炎与代谢综合征相关机制的系统综述

doi:10.3969/j.issn.1009-976X.2021.06.019

摘要/Abstract

摘要： 骨关节炎与代谢综合征均属于全身系统性疾病,二者在发病机制上相互关联,相互促进,与整体氧化应激、炎症反应、血管内皮损伤、遗传基因、激素分泌、代谢异常、肥胖、生物力学改变、高血压及脂质代谢异常等密切相关。积极控制代谢综合征有助于延缓骨关节炎发病进展,改善骨关节炎活动受限有助于减轻代谢综合征,整体观念为临床骨关节炎的诊断及治疗提供又一种思维模式。

关键词: 骨关节炎, 代谢综合征, 发病机制, 综述

Abstract: Both osteoarthritis and metabolic syndrome are systemic diseases, which are closely related to global oxidative stress, inflammatory response, vascular endothelial damage, genetic genes, hormone secretion, metabolic abnormalities, obesity, biomechanical changes, hypertension and lipid metabolism abnormalities. Osteoarthritis and metabolic syndrome are interrelated and promote each other in pathogenesis. Actively controlling of metabolic syndrome,the progression of osteoarthritis can be alleviated. Improving osteoarthritis activity limitations, metabolic syndrome maybe improved. Because of the holistic concept, another thinking model for clinical diagnosis and treatment of osteoarthritis is provided.

Key words: osteoarthritis, metabolic syndrome, pathogenesis, review

中图分类号:

R681.5

李波. 骨关节炎与代谢综合征相关机制的系统综述[J]. 岭南现代临床外科, 2021, 21(06): 679-683.

LI Bo. A systematic review of the mechanisms of osteoarthritis and metabolic syndrome[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 679-683.

参考文献

[1] Mobasheri A, Rayman M, Gualillo O, et al.The role of metabolism in the pathogenesis of osteoarthritis[J]. Nat Rev Rheumatol, 2017, 13(5): 302-311.
[2] Glyn-Jones S, Palmer A, Agricola R, et al.Osteoarthritis[J]. Lancet (London, England), 2015, 386(9991): 376-387.
[3] Hunter D, March L, Chew M.Osteoarthritis in 2020 and beyond: a Lancet Commission[J]. Lancet (London, England), 2020, 396(10264): 1711-1712.
[4] He M, Zhong X, Li Z, et al.Progress in the treatment of knee osteoarthritis with high tibial osteotomy: a systematic review[J]. Syst Rev, 2021, 10(1): 56.
[5] Berenbaum F, Griffin T, Liu-Bryan R.Review: Metabolic Regulation of Inflammation in Osteoarthritis[J]. Arthritis Rheumatol, 2017, 69(1): 9-21.
[6] Liu SY, Zhu WT, Chen BW, et al.Bidirectional association between metabolic syndrome and osteoarthritis: a meta-analysis of observational studies[J]. Diabetol Metab Syndr, 2020, 12: 38.
[7] Tootsi K, Märtson A, Kals J, et al.Metabolic factors and oxidative stress in osteoarthritis: a case-control study[J]. Scand J Clin Lab Invest, 2017, 77(7): 520-526.
[8] Katz J, Agrawal S, Velasquez M.Getting to the heart of the matter: osteoarthritis takes its place as part of the metabolic syndrome[J]. Curr OpinRheumatol, 2010, 22(5): 512-519.
[9] Carrier A.Metabolic Syndrome and Oxidative Stress: A Complex Relationship[J]. Antioxid Redox Signal, 2017, 26(9): 429-431.
[10] Monserrat-Mesquida M, Quetglas-Llabrés M, Capó X, et al.Metabolic Syndrome is Associated with Oxidative Stress and Proinflammatory State[J]. Antioxidants (Basel), 2020, 9(3): 236.
[11] Scott J, Gabrielides C, Davidson R, et al.Superoxide dismutase downregulation in osteoarthritis progression and end-stage disease[J]. Ann Rheum Dis, 2010, 69(8): 1502-1510.
[12] Kluzek S, Newton J, Arden N.Is osteoarthritis a metabolic disorder?[J]. Br Med Bull, 2015, 115(1): 111-121.
[13] Kriegova E, Manukyan G, Mikulkova Z, et al.Gender-related differences observed among immune cells in synovial fluid in knee osteoarthritis[J]. Osteoarthritis Cartilage, 2018, 26(9): 1247-1256.
[14] Valdes A.Metabolic syndrome and osteoarthritis pain: common molecular mechanisms and potential therapeutic implications[J]. Osteoarthritis Cartilage, 2020, 28(1): 7-9.
[15] Guss J, Ziemian S, Luna M, et al.The effects of metabolic syndrome, obesity, and the gut microbiome on load-induced osteoarthritis[J]. Osteoarthritis Cartilage, 2019, 27(1): 129-139.
[16] Herrero-Beaumont G, Pérez-Baos S, Sánchez-Pernaute O, et al.Targeting chronic innate inflammatory pathways, the main road to prevention of osteoarthritis progression[J]. Biochem Pharmacol, 2019, 165: 24-32.
[17] Zhang B, Hu X, Wang H, et al.Effects of a dammarane-type saponin, ginsenoside Rd, in nicotine-induced vascular endothelial injury[J]. Phytomedicine, 2020, 79: 153325.
[18] Le Clanche S, Bonnefont-Rousselot D, Sari-Ali E, et al.Inter-relations between osteoarthritis and metabolic syndrome: A common link?[J]. Biochimie, 2016, 121: 238-252.
[19] Zhuo Q, Yang W, Chen J, et al.Metabolic syndrome meets osteoarthritis[J]. Nat Rev Rheumatol, 2012, 8(12): 729-737.
[20] Collins K, Herzog W, Macdonald G, et al.Obesity, Metabolic Syndrome, and Musculoskeletal Disease: Common Inflammatory Pathways Suggest a Central Role for Loss of Muscle Integrity[J]. Front Physiol, 2018, 9: 112.
[21] Bortoluzzi A, Furini F, Scirè C.Osteoarthritis and its management - Epidemiology, nutritional aspects and environmental factors[J]. Autoimmun Rev, 2018, 17(11): 1097-1104.
[22] Berenbaum F, Wallace I, Lieberman D, et al.Modern-day environmental factors in the pathogenesis of osteoarthritis[J]. Nat Rev Rheumatol, 2018, 14(11): 674-681.
[23] Zhang C, Lv M, Han B, et al.Research on the correlation between the polymorphism of the back-2 gene and osteoarthritis[J]. Eur Rev Med PharmacolSci, 2018, 22(1 Suppl): 76-82.
[24] Kostopoulou F, Malizos K, Papathanasiou I, et al.MicroRNA-33a regulates cholesterol synthesis and cholesterol efflux-related genes in osteoarthritic chondrocytes[J]. Arthritis Res Ther, 2015, 17(1): 42.
[25] Lee B, Yang S, Kwon S, et al.Association between metabolic syndrome and knee osteoarthritis: A cross-sectional nationwide survey study[J]. J Rehabil Med, 2019, 51(6): 464-470.
[26] Bay-Jensen A, Slagboom E, Chen-An P, et al.Role of hormones in cartilage and joint metabolism: understanding an unhealthy metabolic phenotype in osteoarthritis[J]. Menopause, 2013, 20(5): 578-586.
[27] Askari A, Ehrampoush E, Homayounfar R, et al.Serum insulin in pathogenesis and treatment of osteoarthritis[J]. Med Hypotheses, 2017, 99: 45-46.
[28] Rada I, Deldicque L, Francaux M, et al.Toll like receptor expression induced by exercise in obesity and metabolic syndrome: A systematic review[J]. Exerc Immunol Rev, 2018, 24:60-71.
[29] Nie F, Ding F, Chen B, et al.Dendritic cells aggregate inflammation in experimental osteoarthritis through a toll-like receptor (TLR)-dependent machinery response to challenges[J]. Life Sci, 2019, 238: 116920.
[30] Huang Z, Kraus V.Does lipopolysaccharide-mediated inflammation have a role in OA?[J]. Nat RevRheumatol, 2016, 12(2): 123-129.
[31] Dickson B, Roelofs A, Rochford J, et al.The burden of metabolic syndrome on osteoarthritic joints[J]. Arthritis Res ther, 2019, 21(1): 289.
[32] Xie C, Chen Q.Adipokines: New Therapeutic Target for Osteoarthritis?[J]. Curr Rheumatol Rep, 2019, 21(12): 71.
[33] Liu B, Gao Y, Dong N, et al.Differential expression of adipokines in the synovium and infrapatellar fat pad of osteoarthritis patients with and without metabolic syndrome[J]. Connect Tissue Res, 2019, 60(6): 611-618.
[34] Silvestre M, Rodrigues A, Canhão H, et al.Cross-Talk between Diet-Associated Dysbiosis and Hand Osteoarthritis[J]. Nutrients, 2020, 12(11):3469.
[35] Berenbaum F, Walker C.Osteoarthritis and inflammation: a serious disease with overlapping phenotypic patterns[J]. Postgrad Med, 2020, 132(4): 377-384.
[36] Abella V, Scotece M, Conde J, et al.Adipokines, metabolic syndrome and rheumatic diseases[J]. J Immunol Res, 2014, 2014: 343746.
[37] Xie Y, Zhou W, Zhong Z, et al.Metabolic syndrome, hypertension, and hyperglycemia were positively associated with knee osteoarthritis, while dyslipidemia showed no association with knee osteoarthritis[J]. Clin Rheumatol, 2021, 40(2): 711-724.
[38] Hashimoto K, Akagi M.The role of oxidation of low-density lipids in pathogenesis of osteoarthritis: A narrative review[J]. J Int Med Res, 2020, 48(6): 300060520931609.
[39] Kulkarni P, Martson A, Vidya R, et al.Pathophysiological landscape of osteoarthritis[J]. Adv Clin Chem, 2021, 100: 37-90.
[40] Onkarappa R, Chauhan D, Saikia B, et al.Metabolic Syndrome and Its Effects on Cartilage Degeneration vs Regeneration: A Pilot Study Using Osteoarthritis Biomarkers[J]. Indian J Orthop, 2020, 54(Suppl 1): 20-24.